What question did this study set out to answer?

To review available evidence on the clinical utility of platelet function monitoring during clopidogrel therapy and explore the discrepancies between observational data and guideline recommendations.

March 1, 2011Interventional Medicine and Applied ScienceOpen Access

Platelet function monitoring in patients on clopidogrel

View Full Paper

Ask AI

Bookmark

Why the study?

Does platelet function monitoring improve clinical outcomes in patients with acute coronary syndromes and after PCI receiving clopidogrel?

Key Points

To review available evidence on the clinical utility of platelet function monitoring during clopidogrel therapy and explore the discrepancies between observational data and guideline recommendations.
Reviewed observational literature and guideline consensus statements addressing platelet reactivity in patients treated with clopidogrel.
Evaluated ischemic complications following percutaneous coronary interventions and acute coronary syndromes in relation to high on-treatment platelet reactivity (HTPR).
High on-treatment platelet reactivity persists in approximately one third of patients receiving clopidogrel.
Observational studies indicate that HTPR correlates with an elevated risk of adverse ischemic events, including stent thrombosis, myocardial infarction, and cardiovascular death.
Current clinical practice guidelines advise against routine platelet function testing despite observational evidence linking HTPR to adverse cardiovascular outcomes.

Structured PICO

Does platelet function monitoring improve clinical outcomes in patients with acute coronary syndromes and after PCI receiving clopidogrel?

Population

Patients with acute coronary syndromes and after percutaneous coronary interventions (PCIs) receiving clopidogrel

Intervention

Platelet function monitoring to tailor anti-platelet therapy

Outcome

Ischemic events (cardiovascular death, myocardial infarction, and stent thrombosis)hard clinical

This review highlights the discrepancy between observational data suggesting benefit from platelet function monitoring in clopidogrel-treated patients and current clinical guidelines that do not recommend routine monitoring.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Highlights discrepancy between observational data and guidelines on platelet function monitoring in clopidogrel-treated ACS/PCI patients; leaves open need for definitive RCTs.

Cite This Study

Aradi et al. (2011) studied this question.

synapsesocial.com/papers/6a7699b0ec1fdabb7369a497 https://doi.org/10.1556/imas.3.2011.1.7

View Full Paper

Ask AI

Bookmark

Implication

Highlights discrepancy between observational data and guidelines on platelet function monitoring in clopidogrel-treated ACS/PCI patients; leaves open need for definitive RCTs.

Platelet function monitoring in patients on clopidogrel

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Platelet function monitoring in patients on clopidogrel

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Also Consider